Human Colon Microbiota Transform Polycyclic Aromatic Hydrocarbons to Estrogenic Metabolites

Abstract

Ingestion is an important exposure route for polycyclic aromatic hydrocarbons (PAHs) to enter the human body. Although the formation of hazardous PAH metabolites by human biotransformation enzymes is well documented, nothing is known about the PAH transformation potency of human intestinal microbiota. Using a gastrointestinal simulator, we show that human intestinal microbiota can also bioactivate PAHs, more in particular to estrogenic metabolites. PAH compounds are not estrogenic, and indeed, stomach and small intestine digestions of 62.5 nmol naphthalene, phenanthrene, pyrene, and benzo(a)pyrene showed no estrogenic effects in the human estrogen receptor bioassay. In contrast, colon digests of these PAH compounds displayed estrogenicity, equivalent to 0.31, 2.14, 2.70, and 1.48 nmol 17α-ethynylestradiol (EE2), respectively. Inactivating the colon microbiota eliminated these estrogenic effects. Liquid chromatography–mass spectrometry analysis confirmed the microbial PAH transformation by the detection of PAH metabolites 1-hydroxypyrene and 7-hydroxybenzo(a)pyrene in colon digests of pyrene and benzo(a)pyrene. Furthermore, we show that colon digests of a PAH-contaminated soil (simulated ingestion dose of 5 g/day) displayed estrogenic activity equivalent to 0.58 nmol EE2, whereas stomach or small intestine digests did not. Although the matrix in which PAHs are ingested may result in lower exposure concentrations in the gut, our results imply that the PAH bioactivation potency of colon microbiota is not eliminated by the presence of soil. Moreover, because PAH toxicity is also linked to estrogenicity of the compounds, the PAH bioactivation potency of colon microbiota suggests that current risk assessment may underestimate the risk from ingested PAHs.

Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?

“…Their metabolism involves oxidation reactions by cytochrome P450s, followed by phase 2 conjugation with typically glucuronic acid, glutathione, or sulfate. Recent results obtained using a simulator of the human microbiota indicate that the microbiota obtained from the human colon, but not the stomach or small intestine, is capable of biotransforming the polyaromatic compounds naphthalene, phenanthrene, pyrene, and benzo[a]pyrene (Van de Wiele et al, 2005). Interestingly, the reactions appeared to involve the formation of hydroxyl metabolites, which, unlike the parent compounds, exhibit estrogenic activities.…”

Association between a biomarker of exposure to polycyclic aromatic hydrocarbons and semen quality

“…PAHs and their metabolites may be hormonally active [48,49]. PAHs can bind and stimulate the acryl hydrocarbon receptor (AhR) which, in turn, may induce increased metabolism of PAHs to biologically active products that can interact with DNA and promote cancer, or other adverse outcomes [50].…”

Microbial Community Development in a Dynamic Gut Model Is Reproducible, Colon Region Specific, and Selective for Bacteroidetes and Clostridium Cluster IX

“…Other advantages are the lack of ethical constraints and a higher reproducibility due to strict control of environmental factors that can influence the microbiota, such as retention time, pH, temperature, and food intake. Therefore, in vitro methods are widely used to elucidate the mechanism behind the degradation of prebiotics (17,52), bioactivation of polyphenols (10,36,38), adhesion of microbes to mucins (51), or bioavailability of environmental contaminants (53,54).…”